Occidental Petroleum Is Crushing the Market in 2026. Is It the Smartest Buy Right Now?

Occidental Petroleum shares are up nearly 40% year to date, boosted by higher oil prices from the U.S.-Iran war and record production of 1,434 Mboed. Berkshire Hathaway's $9.7 billion OxyChem purchase and 26.7% stake have improved the balance sheet and investor sentiment. However, the stock now trades at roughly 40x forward earnings, and only 8 of 26 analysts rate it a buy or strong buy.

Analysis

The market is rewarding OXY for being a high-beta proxy on oil while also de-risking the balance sheet, but that combination is likely to compress future upside rather than extend it. Berkshire’s capital allocation support has created an implicit floor in the equity, yet the same sponsor effect tends to attract momentum flows late in a cycle, when the easy multiple re-rate has already occurred. The result is a stock that can still work as a hedge on near-term geopolitical shocks, but is increasingly expensive as a standalone compounder.

Second-order, the stronger relative performance of OXY versus CVX/XOM says less about superior operations and more about factor exposure: leverage to crude and a cleaner story after asset monetization. That makes OXY more vulnerable if the market starts pricing a normalization of oil rather than a sustained supply shock. If crude mean-reverts even modestly over the next 1-3 months, OXY’s elevated forward multiple should prove fragile versus peers with larger downstream/chemicals diversification and lower earnings volatility.

The overlooked risk is that this rally has likely pulled forward the geopolitical premium. Energy equities usually discount conflict quickly, but the real earnings impact lags; if the situation stabilizes without a durable supply loss, investors are left owning a rich multiple on peak sentiment. In that scenario, the better expression is not outright bearish energy, but rotation from the highest-multiple beneficiary into cheaper cash-flow names or into structural hedges that don’t rely on sustained war risk.

Consensus is missing how much of the current move is financial engineering plus narrative, not just fundamentals. Berkshire’s endorsement matters, but it does not immunize the stock from multiple compression when the market shifts from 'scarcity' to 'normalize and harvest.' The asymmetry now favors owning optionality on a further oil spike, not paying 40x forward earnings for already rerated exposure.

Key Decisions for Investors

• Trim/avoid initiating fresh long OXY here; use a 1-3 month horizon and treat the name as a geopolitical hedge only, not a core energy overweight, because upside is increasingly capped by valuation compression risk.
• Pair trade: long CVX or XOM / short OXY for 2-4 months. Rationale: lower-multiple peers have more diversified earnings and should hold up better if crude retreats, while OXY’s higher beta makes it more vulnerable to any normalization in oil.
• For traders wanting convexity, buy OXY call spreads 6-10 weeks out instead of stock. This captures residual war-premium upside while limiting downside if the geopolitical premium fades quickly.
• If already long OXY, hedge with a short-dated energy ETF put or a partial short in XLE for 4-8 weeks; this reduces exposure to a broad energy fade while retaining idiosyncratic Berkshire support.
• Monitor any stabilization headlines from the Middle East over the next 30-60 days; on a crude pullback, rotate capital from OXY into cheaper energy cash-flow names immediately, as the multiple gap should close faster than fundamentals deteriorate.